Protein and mRNA expression assays confirmed co-expression of both ERα and DOT1L in PEO cells, even though their level was slightly different between the two, and lower when compared to those of breast cancer MCF7 cells used for comparison (Figure 1d,e). This evidence concerns the gene ESR1 and breast carcinoma.